The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples